AU3211584A – Composition
– Google Patents
AU3211584A – Composition
– Google Patents
Composition
Info
Publication number
AU3211584A
AU3211584A
AU32115/84A
AU3211584A
AU3211584A
AU 3211584 A
AU3211584 A
AU 3211584A
AU 32115/84 A
AU32115/84 A
AU 32115/84A
AU 3211584 A
AU3211584 A
AU 3211584A
AU 3211584 A
AU3211584 A
AU 3211584A
Authority
AU
Australia
Prior art keywords
protozoa
gel matrix
host
alginate
coccidia
Prior art date
1983-08-04
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU32115/84A
Other versions
AU564879B2
(en
Inventor
Paul James Davis
Peter Harris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever PLC
Original Assignee
Unilever PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1983-08-04
Filing date
1984-08-03
Publication date
1985-03-12
1984-08-03
Application filed by Unilever PLC
filed
Critical
Unilever PLC
1985-03-12
Publication of AU3211584A
publication
Critical
patent/AU3211584A/en
1987-08-27
Application granted
granted
Critical
1987-08-27
Publication of AU564879B2
publication
Critical
patent/AU564879B2/en
2004-08-03
Anticipated expiration
legal-status
Critical
Status
Ceased
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K39/00—Medicinal preparations containing antigens or antibodies
A61K39/002—Protozoa antigens
A61K39/012—Coccidia antigens
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K9/00—Medicinal preparations characterised by special physical form
A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
A61K9/1605—Excipients; Inactive ingredients
A61K9/1629—Organic macromolecular compounds
A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Abstract
An oral vaccine against parasitic protozoa, such as coccidia, comprises live encysted protozoa embedded in a firm gel matrix from which the protozoa are released following ingestion by a host. The gel matrix helps to maintain the essential viability of the protozoa without seriously hindering the natural mechanism by which they infect their host. Preferably the gel matrix is based on alginate. Alginate beadlets containing viable sporulated coccidia oocysts, for administration to poultry, are a preferred feature.
AU32115/84A
1983-08-04
1984-08-03
Composition
Ceased
AU564879B2
(en)
Applications Claiming Priority (2)
Application Number
Priority Date
Filing Date
Title
GB838326633A
GB8326633D0
(en)
1983-08-04
1983-08-04
Compositions
GB8326633
1983-08-04
Publications (2)
Publication Number
Publication Date
AU3211584A
true
AU3211584A
(en)
1985-03-12
AU564879B2
AU564879B2
(en)
1987-08-27
Family
ID=10549705
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU32115/84A
Ceased
AU564879B2
(en)
1983-08-04
1984-08-03
Composition
Country Status (18)
Country
Link
EP
(1)
EP0134703B1
(en)
JP
(1)
JPS60501955A
(en)
AT
(1)
ATE33100T1
(en)
AU
(1)
AU564879B2
(en)
CA
(1)
CA1230554A
(en)
DE
(1)
DE3470004D1
(en)
DK
(1)
DK153685A
(en)
ES
(1)
ES534896A0
(en)
GB
(2)
GB8326633D0
(en)
HU
(1)
HU192579B
(en)
IE
(1)
IE58017B1
(en)
NZ
(1)
NZ209051A
(en)
PL
(1)
PL146426B1
(en)
RO
(1)
RO91501B
(en)
SU
(1)
SU1528329A3
(en)
WO
(1)
WO1985000752A1
(en)
YU
(1)
YU43932B
(en)
ZA
(1)
ZA846039B
(en)
Families Citing this family (34)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
CA1204057A
(en)
*
1982-06-22
1986-05-06
Eng-Hong Lee
Immunization against coccidiosis
US4695463A
(en)
*
1985-05-24
1987-09-22
Warner-Lambert Company
Delivery system for active ingredients and preparation thereof
ZA867327B
(en)
*
1985-11-04
1987-05-27
Warner Lambert Co
Flavored tableted chewing gum
DE3785404T2
(en)
*
1986-08-18
1993-07-29
British Tech Group
Vaccines.
KR940000065B1
(en)
*
1986-08-28
1994-01-05
코 사이 잉 토마스
Animal growth promotant
IL85980A
(en)
*
1987-04-16
1992-03-29
Embrex Inc
Disease control in avian species by embryonal vaccination with a nonreplicating immunogen
US4808404A
(en)
*
1988-01-11
1989-02-28
A. H. Robins Company, Inc.
Live vaccine for coccidiosis utilizing coccidial sporozoites
JPH01313437A
(en)
*
1988-06-14
1989-12-18
Nippon Seibutsu Kagaku Kenkyusho
Particulate live vaccine for administration into feed, production thereof and live vaccine for avian coccidiosis
ZA907737B
(en)
*
1989-09-29
1991-07-31
Nisshin Oil Mills Ltd
Stable immunogen composition for oral administration
US5178882A
(en)
*
1990-06-22
1993-01-12
The Regents Of The University Of California
Viral decoy vaccine
US5278298A
(en)
*
1991-05-29
1994-01-11
Merck & Co., Inc.
Eimeria brunetti 16s rDNA probes
US5298613A
(en)
*
1991-05-29
1994-03-29
Merck And Co., Inc.
Eimeria acervulina 16S rDNA probes
US5359050A
(en)
*
1991-05-29
1994-10-25
Merck And Co., Inc.
Eimeria mitis 16S or DNA probes
US5288845A
(en)
*
1991-05-29
1994-02-22
Merck And Co., Inc.
Eimeria necatrix 16s rDNA probes
US5563256A
(en)
*
1991-05-29
1996-10-08
Merck & Co., Inc.
Eimeria tenella 16S rDNA probes
US5266689A
(en)
*
1991-05-29
1993-11-30
Merck And Co., Inc.
Eimeria maxima 165 rDNA probes
US5449768A
(en)
*
1991-05-29
1995-09-12
Merck And Co., Inc.
Eimeria praecox 16S rDNA probes
FR2683147B1
(en)
*
1991-10-30
1995-06-23
Maingault Philippe
VEHICLE SYSTEM OF ACTIVE INGREDIENT FOR ORAL ADMINISTRATION IN FISH AND CRUSTACEANS.
DE4325658C2
(en)
*
1993-07-30
1995-06-08
Chevita Tierarzneimittel Ges M
Process for the production of feed containing pharmacologically active substances
GB9500863D0
(en)
1995-01-17
1995-03-08
Grampian Pharm Ltd
Medicated animal foodstuffs
ES2205014T3
(en)
*
1995-02-21
2004-05-01
Eng-Hong Lee
GELIFIED FORM OF A VACCINE.
DE69922512T2
(en)
*
1998-07-08
2005-12-15
Kiwicare Corporation Ltd., Bromley
PESTICIDE IN YELLOW
DE10023401A1
(en)
*
2000-05-12
2001-11-15
Bayer Ag
Rodenticidal composition containing sporocysts of pathogenic protozoa in water-containing gel, optionally together with bait, retains water content and infectious activity on prolonged storage
US6656470B2
(en)
2000-05-12
2003-12-02
Pharmacia & Upjohn Company
Vaccine composition, method of preparing the same, and method of vaccinating vertebrates
AU2001259660A1
(en)
*
2000-05-26
2001-12-11
Novus International Inc
Particulate feed for young poultry
CA2464522C
(en)
*
2004-04-15
2011-11-15
Eng-Hong Lee
Soft gel delivery system for treating poultry
TW201010717A
(en)
2008-05-29
2010-03-16
Intervet Int Bv
Coccidiosis vaccines
US8252292B2
(en)
2008-11-13
2012-08-28
Intervet International B.V.
Eimeria vaccine for turkeys
US8858959B2
(en)
*
2011-07-15
2014-10-14
The United States Of America, As Represented By The Secretary Of Agriculture
Gel vaccine delivery system for treating poultry
US9603368B2
(en)
2012-09-17
2017-03-28
University Of Connecticut
Microbial carriers for targeted delivery of agricultural payloads
RU2504365C1
(en)
*
2012-12-25
2014-01-20
Айгуль Зарифовна Журавлева
Method of preventing coccidiosis of broiler chickens in their growing for parent stock
RU2505287C1
(en)
*
2012-12-25
2014-01-27
Айгуль Зарифовна Журавлева
Method for prevention of coccidiosis of broiler chickens when rearing them for meat
CA3096920A1
(en)
*
2018-04-17
2019-10-24
Clearh2O, Inc.
Alginate beads and methods of manufacture and use thereof
WO2022192956A1
(en)
*
2021-03-17
2022-09-22
The University Of Melbourne
Encystment and stabilisation of ciliate protozoa cells
Family Cites Families (6)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
BE670837A
(en)
*
1964-10-14
1966-01-31
GB1218277A
(en)
*
1968-08-20
1971-01-06
Miles Lab
Dry water-dispersible aluminium hydroxide gels
GB1218278A
(en)
*
1968-08-20
1971-01-06
Miles Lab
Stabilised aluminium hydroxide suspensions
US4148689A
(en)
*
1976-05-14
1979-04-10
Sanraku-Ocean Co., Ltd.
Immobilization of microorganisms in a hydrophilic complex gel
FR2408351B1
(en)
*
1977-11-14
1983-10-28
Unilever Nv
SE7907035L
(en)
*
1979-08-23
1981-02-24
Berbel Hegerdal
PROCEDURE FOR THE PRODUCTION OF LIQUID FUEL FROM BIOLOGICAL RAVAR
1983
1983-08-04
GB
GB838326633A
patent/GB8326633D0/en
active
Pending
1984
1984-07-30
NZ
NZ209051A
patent/NZ209051A/en
unknown
1984-08-01
YU
YU1344/84A
patent/YU43932B/en
unknown
1984-08-03
DE
DE8484305302T
patent/DE3470004D1/en
not_active
Expired
1984-08-03
GB
GB08419812A
patent/GB2144331B/en
not_active
Expired
1984-08-03
ZA
ZA846039A
patent/ZA846039B/en
unknown
1984-08-03
EP
EP84305302A
patent/EP0134703B1/en
not_active
Expired
1984-08-03
PL
PL1984249061A
patent/PL146426B1/en
unknown
1984-08-03
CA
CA000460374A
patent/CA1230554A/en
not_active
Expired
1984-08-03
WO
PCT/GB1984/000268
patent/WO1985000752A1/en
unknown
1984-08-03
ES
ES534896A
patent/ES534896A0/en
active
Granted
1984-08-03
AU
AU32115/84A
patent/AU564879B2/en
not_active
Ceased
1984-08-03
JP
JP59502999A
patent/JPS60501955A/en
active
Pending
1984-08-03
HU
HU843340A
patent/HU192579B/en
not_active
IP Right Cessation
1984-08-03
AT
AT84305302T
patent/ATE33100T1/en
not_active
IP Right Cessation
1984-08-08
IE
IE198584A
patent/IE58017B1/en
not_active
IP Right Cessation
1985
1985-04-01
SU
SU853874750A
patent/SU1528329A3/en
active
1985-04-03
DK
DK153685A
patent/DK153685A/en
not_active
Application Discontinuation
1985-04-03
RO
RO118254A
patent/RO91501B/en
unknown
Also Published As
Publication number
Publication date
ES534896A0
(en)
1986-01-01
IE58017B1
(en)
1993-06-16
ATE33100T1
(en)
1988-04-15
PL146426B1
(en)
1989-02-28
EP0134703B1
(en)
1988-03-23
JPS60501955A
(en)
1985-11-14
GB8419812D0
(en)
1984-09-05
RO91501B
(en)
1987-07-03
GB2144331B
(en)
1987-10-14
CA1230554A
(en)
1987-12-22
DE3470004D1
(en)
1988-04-28
RO91501A
(en)
1987-06-30
GB2144331A
(en)
1985-03-06
DK153685A
(en)
1985-04-03
HUT38842A
(en)
1986-07-28
PL249061A1
(en)
1985-04-24
ES8603756A1
(en)
1986-01-01
AU564879B2
(en)
1987-08-27
EP0134703A1
(en)
1985-03-20
SU1528329A3
(en)
1989-12-07
YU134484A
(en)
1987-02-28
DK153685D0
(en)
1985-04-03
GB8326633D0
(en)
1983-11-09
YU43932B
(en)
1989-12-31
HU192579B
(en)
1987-06-29
ZA846039B
(en)
1986-03-26
IE841985L
(en)
1985-02-04
WO1985000752A1
(en)
1985-02-28
NZ209051A
(en)
1988-06-30
Similar Documents
Publication
Publication Date
Title
AU3211584A
(en)
1985-03-12
Composition
NO20004326D0
(en)
2000-08-31
Purine L nucleosides, analogs and uses thereof
MX9306841A
(en)
1995-01-31
UREASE BASED VACCINE AGAINST HELICOBACTER INFECTION IN MAMMALS.
NZ225106A
(en)
1990-10-26
Compositions which include amino acids, metabolites an electrolyte and ribose
AU6117696A
(en)
1996-12-30
Nucleic acid respiratory syncytial virus vaccines
DK442287D0
(en)
1987-08-25
PHARMACEUTICAL PREPARATION CONTAINING L-3,4-DIHYDROXYPHENYLALANINE (L-DOPA) AS ACTIVE INGREDIENT AND PROCEDURE FOR THE PREPARATION OF SUCH PREPARATION
AU8314587A
(en)
1988-07-07
New oligosaccharides, immunogens and vaccines, and methods for preparing such oligosaccharides, immunogens and vaccines
PT88306A
(en)
1989-06-30
METHOD FOR THE PREPARATION OF 2 ', 3'-DIDEOXY-3'-FLUORO-PYRIMIDINE NUCLEOSIDES AND OF PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AU617318B2
(en)
1991-11-28
Outer membrane protein f of pseudomonas aeruginosa
PT90661A
(en)
1989-11-30
PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS CONTAINING INHIBITORS OF THE ANGIOTENSIN CONVERSORA ENZYME AND POTASSIO CHANNEL MODULATORS
ES2079349T3
(en)
1996-01-16
SALTS BY ADDITION OF CRYSTALLIZED CEFEM ACIDS AND PROCEDURE FOR THEIR PREPARATION.
MX8958A
(en)
1993-12-01
PROCEDURE FOR OBTAINING A LYOPHILIZED PREPARATION CONTAINING IFOSFAMIDE.
IT1232819B
(en)
1992-03-05
USE OF NUCLEOBASE SOURCES TO STIMULATE THE IMMUNE FUNCTION, RELATIVE PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH SOURCE OF NUCLEOBASE
ES506116A0
(en)
1982-08-16
PROCEDURE FOR OBTAINING ISOMALTULOSE FROM SACAROSA
DE3871012D1
(en)
1992-06-17
THERAPEUTIC AGENTS CONTAINING ENANTIOMERS OF PROPAFENON.
TH2210EX
(en)
1985-02-01
Components for inducing immunity against parasitic protozoa.
TH8735B
(en)
1999-01-18
Vaccine
GT198500078A
(en)
1987-02-18
IMMUNE-STIMULATING MULTI-VACCINE VACCINE
None